Skip to the main content

Review article

Sustavno antineoplastično liječenje metastatskog raka dojke

Robert Šeparović orcid id orcid.org/0000-0002-4002-2699 ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Robert Zorica ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Tajana Silovski orcid id orcid.org/0000-0002-4699-5432 ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Mirjana Pavlović orcid id orcid.org/0000-0002-9633-064X ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Ljubica Vazdar ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Vesna Pavlica ; Hospital Pharmacy; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia


Full text: english pdf 185 Kb

page 51-60

downloads: 184

cite


Abstract

Sustavno liječenje metastatskog raka dojke nije kurativno već se provodi u svrhu produženja života i poboljšanja kvalitete života. Sustavno liječenje se sastoji od endokrine terapije i/ili kemoterapije uz ili bez primjene ciljane biološke terapije. U liječenju metastatskog raka dojke preferirani oblici liječenja su oni najmanje toksični te se endokrina terapija primjenjuje
kad god je to moguće.

Keywords

karcinom dojke; hormonska terapija; citotoksični lijekovi; biološka terapija; bisfosfonati

Hrčak ID:

199079

URI

https://hrcak.srce.hr/199079

Publication date:

29.12.2014.

Article data in other languages: english

Visits: 1.707 *